Influenza Vaccines - Pipeline Assessment 2017 Now Available at SandlerResearch

Dallas, TX -- (SBWire) -- 11/22/2010 -- SandlerResearch announce Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017

Original Source : Influenza Vaccines Market
http://www.sandlerresearch.org/reports/36584-influenza-vaccines-pipeline-assessment-and-market-forecasts-to-.html

Buy Now : Market Research
http://www.sandlerresearch.org/reports/15763-major-depressive-disorder-mdd-drug-pipeline-analysis-and-mark.html

Browse complete Report at : Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/36584-influenza-vaccines-pipeline-assessment-and-market-forecasts-to-.html

GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Influenza Vaccines market. The report identifies the key trends shaping and driving the global Influenza Vaccines market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. Most importantly, the report provides valuable insights into the pipeline products within the global Influenza Vaccines sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData estimated the global influenza vaccines market to be worth $2.8 billion in 2009. It is forecast to grow at a CAGR of 8% to reach $5 billion by 2017. This high growth forecast is primarily attributed to an increase in the patient population as a result of the increasing world population, and the need to get vaccinated each year. This growth will be further supported by increased production capacities of companies to cater to the rising demand. The strong product pipeline will complement the existing products by providing effective treatment options

Scope
The scope of the report includes:
Annualized global Influenza Vaccines market revenue data from 2001 to 2009, forecast for eight years to 2017.

Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.

Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall in five major vaccine classes: inactivated vaccine, live attenuated vaccine, DNA vaccine, antigenic vaccine and others. Pipeline analysis covers the vaccines which are in early or late stage of development for Influenza.

Analysis of the current and future market competition in the global Influenza Vaccines market. The key future market players covered are Novartis, CSL Limited, MedImmune, GSK and Sanofi Aventis.

Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Key topics covered include a strategic competitor assessment, a market characterization, the unmet needs and the implications for the Influenza Vaccines market.

Reasons to buy
The report will enhance your decision making capability. It will allow you to:

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.

Develop business strategies by understanding the trends shaping and driving the global Influenza Vaccines market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to affect the global Influenza Vaccines market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify the emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investments and strategic partnerships.

What’s the next big thing in the global Influenza Vaccines market landscape? Identify, understand and capitalize

1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Influenza Vaccines: Introduction 6
2.1 Guidelines for the Administration of Influenza Vaccines 6
2.2 GlobalData Pipeline Report Guidance 6

3 Influenza Vaccines: Market Characterization 8
3.1 Influenza Vaccines Market Size 8
3.2 Influenza Vaccines Market Forecast and CAGR 9
3.3 Drivers and Barriers for Influenza Vaccines Market 10
3.3.1 Drivers for Influenza Vaccines Market 10
3.3.2 Barriers for Influenza Vaccines Market 10
3.4 Opportunity and Unmet Need 11
3.5 Key Takeaway 12

4 Influenza Vaccines Market: Competitive Assessment 13
4.1 Overview 13
4.2 Strategic Competitor Assessment 13
4.3 Product Profile for the Major Marketed Vaccines in the Influenza Market 14
4.3.1 Fluzone 14
4.3.2 Flumist 15
4.3.3 Fluarix 15
4.3.4 Fluvirin 16
4.3.5 FluLaval 17
4.3.6 Optaflu 18
4.3.7 Intanza / IDFlu 19
4.4 Comparison of the Major Marketed Products in the Influenza Vaccines Market 20
4.5 Key Takeaway 20

5 Influenza Vaccines Market: Pipeline Assessment 21
5.1 Overview 21
5.2 Strategic Pipeline Assessment 21
5.2.1 Technology Trends Analytical Framework 21
5.3 Influenza Vaccines –Promising Vaccines under Clinical Development 22
5.4 Molecule Profiles for Promising Vaccines under Clinical Development 23
5.4.1 Optaflu 23
5.4.2 Intanza / IDFlu 24
5.4.3 GSK2186877A 24
5.5 Influenza Vaccines Market – Clinical Pipeline by Type of Vaccine 26
5.6 Influenza Vaccines Pipeline – Pipeline by Clinical Phase of Development 26
5.6.1 Influenza Vaccines – Phase III Clinical Pipeline 27
5.6.2 Influenza Vaccines – Phase II Clinical Pipeline 27
5.6.3 Influenza Vaccines – Phase I Clinical Pipeline 28
5.6.4 Influenza Vaccines – Preclinical Pipeline 29
5.6.5 Influenza Vaccines – Discovery Pipeline 29
5.7 Discontinued / Suspended Vaccines for Influenza 30
5.8 Key Takeaway 30

6 Global Influenza Vaccines Market: Implications for Future Market Competition 31

7 Global Influenza Vaccines Market: Future Players in the Influenza Vaccines Market 32
7.1 Introduction 32
7.2 Novartis 32
7.2.1 Company Overview 32
7.2.2 Business Description 33
7.2.3 Infectious Diseases Vaccines Pipeline 33
7.2.4 Influenza Vaccines Pipeline 34
7.3 GlaxoSmithKline 34
7.3.1 Company Overview 34
7.3.2 Business Description 34
7.3.3 Infectious Diseases Vaccines Pipeline 35
7.3.4 Influenza Vaccines Pipeline 35
7.4 Sanofi-aventis 36
7.4.1 Company Overview 36
7.4.2 Business Description 36
7.4.3 Infectious Diseases Vaccines Pipeline 37
7.4.4 Influenza Vaccines Pipeline 37
7.5 CSL Limited 37
7.5.1 Company Overview 37
7.5.2 Business Description 37
7.5.3 Infectious Diseases Vaccines Pipeline 38
7.5.4 Influenza Vaccines Pipeline 38
7.6 MedImmune 39
7.6.1 Company Overview 39
7.6.2 Business Description 39
7.6.3 Infectious Diseases Vaccines Pipeline 40
7.6.4 Influenza Vaccines Pipeline 40

8 Global Influenza Vaccines Market: Appendix 41
8.1 Market Definitions 41
8.2 Scope of Pipeline Research 41
8.3 Abbreviations 41
8.4 Research Methodology 41
8.4.1 Coverage 42
8.4.2 Secondary Research 42
8.4.3 Forecasting 42
8.4.4 Primary Research 45
8.4.5 Expert Panel Validation 45
8.5 Contact Us 45
8.6 Disclaimer 45
8.7 Sources 46

ABBREVIATIONS

Browse all : Pharmaceuticals Market
http://www.sandlerresearch.org/market-research/pharmaceuticals/

Browse all : GlobalData Market
http://www.sandlerresearch.org/publishers/globaldata/

Browse all : Newly Published Market Research
http://www.sandlerresearch.org/LatestReport.aspx

Related Reports:

Seasonal Influenza Vaccines Market Forecast
http://www.sandlerresearch.org/Reports/8047-seasonal-influenza-vaccines-market-forecast.html

Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
http://www.sandlerresearch.org/Reports/8054-commercial-insight-influenza-vaccines-and-antivirals-the-pande.html

Global market review of automotive roof systems – forecasts to 2017
http://www.sandlerresearch.org/Reports/17319-global-market-review-of-automotive-roof-systems-forecasts-to-20.html

H1N1 Swine Influenza Market Assessment Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays
http://www.sandlerresearch.org/Reports/217-h1n1-swine-influenza-market-assessment-latest-data-company-profi.html

Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
http://www.sandlerresearch.org/Reports/25474-global-endoscopes-pipeline-analysis-opportunity-assessment-and-m.html

About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.

Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.

We also provide 24/7 online and offline support to our customers

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/

Media Relations Contact

Ms Sunita
SandlerResearch
888-989-8004
http://www.sandlerresearch.org/

View this press release online at: http://rwire.com/66079